Jo Ann Lindenfeld

Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial

William T. Abraham, Lynne W. Stevenson, Robert C. Bourge et al. · The Lancet · 2015 · 594 citations

Pulmonary Arterial Hypertension, Heart Failure, Cardiovascular Disease +8

Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies

Adita Mascaro‐Blanco, Kathy Alvarez, Xichun Yu et al. · Autoimmunity · 2008 · 78 citations

Cardiac Muscle, Heart Failure, Cardiac Myosin Molecule +20

BOOP is Common in Cardiac Transplant Recipients Switched from a Calcineurin Inhibitor to Sirolimus

Jo Ann Lindenfeld, Shakar F. Simon, Martin R. Zamora et al. · American Journal of Transplantation · 2005 · 45 citations

Transplantation, Medicine, Calcineurin Inhibitor +4

Determination of hospitalization type by investigator case report form or adjudication committee in a large heart failure clinical trial (β-Blocker Evaluation of Survival Trial [BEST])

Peter E. Carson, Mona Fiuzat, Christopher M. O’Connor et al. · American Heart Journal · 2010 · 31 citations

β-Blocker Evaluation, Prognostic Evaluation, Adjudication Committee +7

Predicting response to carvedilol for the treatment of heart failure: A multivariate retrospective analysis

Kimberly Anne Schleman, Jo Ann Lindenfeld, Brian D. Lowes et al. · Journal of Cardiac Failure · 2001 · 27 citations

Heart Failure, Cardiorenal Syndromes, Cardiovascular Disease +8